Cerebral Therapeutics Competitors and Similar CompaniesClear all
Cerebral Therapeutics's competitors and similar companies include ZAI Lab, Veloxis Pharmaceuticals, Oncologie and Apic Bio.
 Cerebral Therapeutics Cerebral Therapeutics is a clinical-stage pharmaceutical company dedicated to improving the lives of patients with uncontrolled neurological diseases. |  ZAI Lab Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases. |  Veloxis Pharmaceuticals Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies. |  Apic Bio Apic Bio is a gene therapy company developing novel treatment options for patients with rare genetic diseases. | ||
Founding Date | Founding Date 2010 | Founding Date 2014 | Founding Date 2002 | Founding Date 2018 | Founding Date 2017 |
Type | Type Private | Type Public | Type Subsidiary | Type Private | Type Private |
Tags | |||||
Locations | Locations Aurora, US HQ Oakdale, US | Locations CN HQ Suzhou, CN Hong Kong, HK Taipei, TW Cambridge, US Menlo Park, US | Locations København, DK HQ Cary, US Cary, US | Locations Waltham, US HQ Shanghai, CN Boston, US | Locations Cambridge, US HQ Cambridge, US |
Employees | Employees 2 | Employees 1,869 | Employees 54 | Employees 8 | Employees 6 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $460.2m (FY, 2025) | Revenue (est.) kr39.5m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $190.5m (FY, 2025) | Cost of goods kr7.9m (FY, 2018) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $269.6m (FY, 2025) | Gross profit kr31.6m (FY, 2018) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income ($175.5m) (FY, 2025) | Net income (kr5.3m) (FY, 2018) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 7.8m (about 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 80m (almost 7 years ago) | Latest funding round $ 40m (over 7 years ago) |
Total funding raised | Total funding raised $ 10.8m | Total funding raised $ 985m | Total funding raised $ 60m | Total funding raised $ 96.5m | Total funding raised $ 51m |
For sources of this data, please see the company profile
View Company Profiles
ZAI Lab
HQ
CN
Employees
1,869
Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases.
View companyVeloxis Pharmaceuticals
HQ
København, DK
Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies.
View companyApic Bio
HQ
Cambridge, US
Employees
6
Apic Bio is a gene therapy company developing novel treatment options for patients with rare genetic diseases.
View company